Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Dennis Cho, a Twist Bioscience executive, sold 272 shares of common stock on March 6, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On March 6, 2024, Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp, sold 272 shares of common stock.
  • The sale was executed at a price of $37.43 per share.
  • This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units and wasn't a discretionary trade.
  • Following the transaction, Cho directly owns 81,456 shares of Twist Bioscience Corp.
  • Some of these shares were acquired under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax obligations. Monitoring these transactions can provide insights into executive sentiment and company performance.

Stakeholder Impact

  • The sale has a minimal impact on shareholders as it's a small transaction related to tax obligations.

Key Dates

DateDescription
03/06/2024Date of stock sale transaction.
03/08/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.